生物标志物 生物标志物
Richard Camicioli1, Sandra E Black2, Michael J Borrie3,4
1University of Alberta, Edmonton, AB, Canada.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
概括
患有莱维体轻度认知障碍 (LB-MCI) 个体表现出高的tau-181和降低的粉样β (Aß) 水平,表明阿尔茨海默氏症共同病理. 这些血液生物标志物表明LB-MCI患者的病理负担较高.
科学领域:
- 神经学 神经学
- 生物化学 生化学
- 神经科学是一个神经科学.
背景情况:
- 轻度认知障碍 (MCI) 可能源于混合病理,使诊断复杂化.
- 对于阿尔茨海默氏症病理和神经退行症的血液生物标志物在莱维体轻度认知障碍 (LB-MCI) 中未得到充分研究.
- LB-MCI的特点是认知波动,帕金森症,幻觉和REM睡眠行为障碍 (RBD).
研究的目的:
- 为了比较LB-MCI患者的血生物标志物水平与没有LB特征的MCI患者,健康对照 (HC) 和患有或没有MCI的帕金森病 (PD) 患者.
- 通过使用血液标记物来调查LB-MCI中阿尔茨海默氏病共同病理的存在.
主要方法:
- 在COMPASS-ND研究的参与者中,使用Simoa测量了粉样β (Aß) 42/40比率,tau-181,GFAP和NfL的血水平.
- 根据既定标准,MCI参与者被归类为LB-MCI.
- 进行了跨组的统计比较 (ANOVA,ANCOVA),根据年龄和性别进行了调整.
主要成果:
- 与没有LB特征的HC,PD和MCI相比,LB-MCI组显示出明显较低的Aß 42/40比率和更高的tau-181.
- 血GFAP和NfL水平在研究组之间没有显著差异.
- 年龄和性别调整并没有改变这些初步发现.
结论:
- LB-MCI患者表现出血生物标志物概况,表明同时存在阿尔茨海默氏症的共同病理.
- 在LB-MCI中升高的tau-181表明潜在的更高的病理性大脑负担.
- 需要进一步的研究来探索这些患者群体中的其他共同病理和突核病理.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516